Paclitaxel enhances carboplatin-DNA adduct formation and cytotoxicity
S Jiang, AW Pan, T Lin, H Zhang… - Chemical research in …, 2015 - ACS Publications
This rapid report focuses on the pharmacodynamic mechanism of the carboplatin/paclitaxel
combination and correlates it with its cytotoxicity. Consistent with the synergistic to additive …
combination and correlates it with its cytotoxicity. Consistent with the synergistic to additive …
[HTML][HTML] Temporal effects of combined birinapant and paclitaxel on pancreatic cancer cells investigated via large-scale, ion-current-based quantitative proteomics …
Despite decades of effort, pancreatic adenocarcinoma (PDAC) remains an intractable
clinical challenge. An insufficient understanding of mechanisms underlying tumor cell …
clinical challenge. An insufficient understanding of mechanisms underlying tumor cell …
[HTML][HTML] Plant mediated biosynthesis of Mn3O4 nanostructures and their biomedical applications
DN Binjawhar, NM Al-Enazi, K Alsamhary, M Kha - Heliyon, 2024 - cell.com
Nanomaterials have drawn significant attention for their biomedical and pharmaceutical
applications. In the present study, manganese tetra oxide (Mn 3 O 4) nanoparticles were …
applications. In the present study, manganese tetra oxide (Mn 3 O 4) nanoparticles were …
Activatable Molecular Systems Using Homologous Near-Infrared Fluorescent Probes for Monitoring Enzyme Activities in Vitro, in Cellulo, and in Vivo
We have developed a generic approach to determine enzyme activities in vitro and monitor
their functional status in vivo. Specifically, a method to generate donor (CbOH)− acceptor …
their functional status in vivo. Specifically, a method to generate donor (CbOH)− acceptor …
[HTML][HTML] Caspase-2 is involved in cell death induction by taxanes in breast cancer cells
M Jelínek, K Balušíková, D Kopperová… - Cancer cell …, 2013 - Springer
Background We studied the role of caspase-2 in apoptosis induction by taxanes (paclitaxel,
novel taxane SB-T-1216) in breast cancer cells using SK-BR-3 (nonfunctional p53 …
novel taxane SB-T-1216) in breast cancer cells using SK-BR-3 (nonfunctional p53 …
Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin's lymphoma
A Chatzitolios, I Venizelos, G Tripsiannis… - Annals of …, 2010 - Springer
Apoptosis-related proteins play an important role in lymphoma cell death during
chemotherapy. In our study, we investigated the prognostic significance of CD95, BCL2, and …
chemotherapy. In our study, we investigated the prognostic significance of CD95, BCL2, and …
[HTML][HTML] Daphnoretin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells
S Gu, J He - Molecules, 2012 - mdpi.com
In this study antiproliferation, cell cycle arrest and apoptosis induced by daphnoretin in
human osteosarcoma (HOS) cells were investigated. Antiproliferative activity was measured …
human osteosarcoma (HOS) cells were investigated. Antiproliferative activity was measured …
[HTML][HTML] The cytotoxic activities of 7-isopentenyloxycoumarin on 5637 cells via induction of apoptosis and cell cycle arrest in G2/M stage
Background Bladder cancer is the second common malignancy of genitourinary tract, and
transitional cell carcinomas (TCCs) account for 90% of all bladder cancers. Due to acquired …
transitional cell carcinomas (TCCs) account for 90% of all bladder cancers. Due to acquired …
Cell death induced by taxanes in breast cancer cells: cytochrome C is released in resistant but not in sensitive cells
M Ehrlichová, M Koc, J Truksa, Z NAĎOVÁ… - Anticancer …, 2005 - ar.iiarjournals.org
Background: The aim of the study was to contribute to our understanding of the mechanisms
responsible for the resistance of breast cancer cells to taxanes. Materials and Methods: Cell …
responsible for the resistance of breast cancer cells to taxanes. Materials and Methods: Cell …
p53 expression and resistance against paclitaxel in patients with metastatic breast cancer
M Schmidt, A Bachhuber, A Victor, E Steiner… - Journal of cancer …, 2003 - Springer
Purpose Paclitaxel is an important agent in the pharmacological treatment of metastatic
breast cancer. Despite its efficacy in selected patients, the majority of patients have a …
breast cancer. Despite its efficacy in selected patients, the majority of patients have a …